Synthesis and Antimicrobial Evaluation of Side-Chain Derivatives based on Eurotiumide A.


Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
30 Jan 2020
Historique:
received: 30 11 2019
revised: 24 01 2020
accepted: 29 01 2020
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 12 11 2020
Statut: epublish

Résumé

Side-chain derivatives of eurotiumide A, a dihydroisochroman-type natural product, have been synthesized and their antimicrobial activities described. Sixteen derivatives were synthesized from a key intermediate of the total synthesis of eurotiumide A, and their antimicrobial activities against two Gram-positive bacteria, methicillin-susceptible and methicillin-resistant

Identifiants

pubmed: 32019233
pii: md18020092
doi: 10.3390/md18020092
pmc: PMC7074549
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Chromans 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Med Chem. 2014 Nov 26;57(22):9292-308
pubmed: 25144261
Trends Mol Med. 2016 Jun;22(6):458-478
pubmed: 27178527
J Nat Prod. 2017 Apr 28;80(4):1215-1228
pubmed: 28362500
Nat Prod Rep. 2017 Jul 1;34(7):712-783
pubmed: 28650032
Nat Rev Microbiol. 2017 May;15(5):259-270
pubmed: 28316330
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
Angew Chem Int Ed Engl. 2006 Aug 4;45(31):5072-129
pubmed: 16881035
J Med Chem. 1996 Sep 27;39(20):3853-74
pubmed: 8831751
Front Microbiol. 2016 Jan 12;6:1543
pubmed: 26793178
Nat Biotechnol. 2006 Dec;24(12):1541-50
pubmed: 17160060
Nature. 2016 Jan 21;529(7586):336-43
pubmed: 26791724
Curr Opin Pharmacol. 2013 Oct;13(5):678-87
pubmed: 23890825
Future Sci OA. 2018 Feb 05;4(4):FSO290
pubmed: 29682325
Cell. 2015 Dec 3;163(6):1326-32
pubmed: 26638069
Nat Prod Rep. 2010 Feb;27(2):238-54
pubmed: 20111803
Nat Rev Drug Discov. 2013 May;12(5):371-87
pubmed: 23629505
Annu Rev Microbiol. 2012;66:371-89
pubmed: 22746335
Antimicrob Agents Chemother. 2000 Jun;44(6):1549-55
pubmed: 10817707
Nat Prod Rep. 2014 Nov;31(11):1612-61
pubmed: 25204227
Rev Infect Dis. 1980 Jan-Feb;2(1):129-39
pubmed: 6994200
Nat Rev Immunol. 2013 Nov;13(11):790-801
pubmed: 24096337
J Med Chem. 2019 Sep 12;62(17):7618-7642
pubmed: 30951303
N Engl J Med. 2016 Dec 15;375(24):2369-2379
pubmed: 27974040
Chem Pharm Bull (Tokyo). 2019;67(9):953-958
pubmed: 31474735

Auteurs

Atsushi Nakayama (A)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Hideo Sato (H)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Tenta Nakamura (T)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Mai Hamada (M)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Shuji Nagano (S)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Shuhei Kameyama (S)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Yui Furue (Y)

Department of Microbiology and Infection Control Sciences, Kyoto Pharmaceutical University, Misasaginakauchi-cho, Yamashita-Ku, Kyoto 607-8414, Japan.

Naoki Hayashi (N)

Department of Microbiology and Infection Control Sciences, Kyoto Pharmaceutical University, Misasaginakauchi-cho, Yamashita-Ku, Kyoto 607-8414, Japan.

Go Kamoshida (G)

Department of Microbiology and Infection Control Sciences, Kyoto Pharmaceutical University, Misasaginakauchi-cho, Yamashita-Ku, Kyoto 607-8414, Japan.

Sangita Karanjit (S)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Masataka Oda (M)

Department of Microbiology and Infection Control Sciences, Kyoto Pharmaceutical University, Misasaginakauchi-cho, Yamashita-Ku, Kyoto 607-8414, Japan.

Kosuke Namba (K)

Graduate School of Pharmaceutical Sciences and Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH